WO1999009186A3 - Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose - Google Patents

Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose Download PDF

Info

Publication number
WO1999009186A3
WO1999009186A3 PCT/FR1998/001813 FR9801813W WO9909186A3 WO 1999009186 A3 WO1999009186 A3 WO 1999009186A3 FR 9801813 W FR9801813 W FR 9801813W WO 9909186 A3 WO9909186 A3 WO 9909186A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycobacteria
mycobacterium
exported
belonging
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR1998/001813
Other languages
English (en)
Other versions
WO1999009186A2 (fr
Inventor
Brigitte Gicquel
Denis Portnoi
Eng-Mong Lim
Vladimir Pelicic
Agnes Guigueno
Salmoniere Yves De La Goguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9710404A external-priority patent/FR2767336B1/fr
Priority to DK98942748T priority Critical patent/DK1003888T3/da
Priority to AU90765/98A priority patent/AU759724B2/en
Priority to CA002301374A priority patent/CA2301374A1/fr
Priority to NZ503316A priority patent/NZ503316A/xx
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to EP98942748A priority patent/EP1003888B1/fr
Priority to DE69839426T priority patent/DE69839426T2/de
Priority to JP2000509849A priority patent/JP2002534956A/ja
Publication of WO1999009186A2 publication Critical patent/WO1999009186A2/fr
Publication of WO1999009186A3 publication Critical patent/WO1999009186A3/fr
Anticipated expiration legal-status Critical
Priority to US09/855,604 priority patent/US7244613B2/en
Priority to US11/329,260 priority patent/US20070015173A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention a pour objet des vecteurs recombinants se réplicant chez les mycobactéries, un ensemble de séquences codant pour des polypeptides exportés détectés par des fusions avec la phosphatase alcaline, notamment un polypeptide, dénommé DP428, d'environ 12kD correspondant à une protéine exportée retrouvée dans les mycobactéries appartenant au complexe de Mycobacterium tuberculosis. L'invention concerne également des procédés et des kits de détection in vitro de la présence d'une mycobactérie et en particulier une mycobactérie appartenant au complexe de Mycobacterium tuberculosis dans un échantillon biologique utilisant lesdits polypeptides, leurs fragments ou des polynucléotides codant pour ces derniers. L'invention vise des compositions immunogènes ou vaccins pour la prévention et/ou le traitement d'infections provoquées par des mycobactéries et en particulier une mycobactérie appartenant audit complexe, en particulier la tuberculose.
PCT/FR1998/001813 1997-08-14 1998-08-14 Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose Ceased WO1999009186A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE69839426T DE69839426T2 (de) 1997-08-14 1998-08-14 Nukleotidsequenzen, die für sekretierte polypeptide aus mycobacterium kodieren, vektoren, die diese enthalten, und anwendungen zur diagnostik und verhütung von tuberkulose
JP2000509849A JP2002534956A (ja) 1997-08-14 1998-08-14 マイコバクテリアから輸送されるポリペプチド核酸配列、それを含んでなるベクター、および結核の診断および予防のための使用
AU90765/98A AU759724B2 (en) 1997-08-14 1998-08-14 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
CA002301374A CA2301374A1 (fr) 1997-08-14 1998-08-14 Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
NZ503316A NZ503316A (en) 1997-08-14 1998-08-14 Polypeptide and nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
DK98942748T DK1003888T3 (da) 1997-08-14 1998-08-14 Nukleinsyresekvenser for polypeptider eksporteret fra mykobakterier, vektorer omfattende disse samt anvendelser til diagnosticering og forebyggelse af tuberkolose
EP98942748A EP1003888B1 (fr) 1997-08-14 1998-08-14 Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
US09/855,604 US7244613B2 (en) 1997-08-14 2001-05-16 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
US11/329,260 US20070015173A1 (en) 1997-08-14 2006-01-11 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9710404A FR2767336B1 (fr) 1997-08-14 1997-08-14 Vecteurs recombinants, polynucleotide codant pour un polypeptide pd428 de 12kd de mycobacteries appartenant au complexe de mycobacterium tuberculosis et applications au diagnostic et a la prevention de la tuberculose
FR97/10404 1997-08-14
FR97/11325 1997-09-11
FR9711325A FR2767337B1 (fr) 1997-08-14 1997-09-11 Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US48553698A A-371-Of-International 1997-08-14 1998-08-14
US48553698A Continuation-In-Part 1997-08-14 1998-08-14
US09/855,604 Continuation US7244613B2 (en) 1997-08-14 2001-05-16 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis

Publications (2)

Publication Number Publication Date
WO1999009186A2 WO1999009186A2 (fr) 1999-02-25
WO1999009186A3 true WO1999009186A3 (fr) 1999-08-05

Family

ID=26233752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1998/001813 Ceased WO1999009186A2 (fr) 1997-08-14 1998-08-14 Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose

Country Status (13)

Country Link
US (2) US7244613B2 (fr)
EP (2) EP1003888B1 (fr)
JP (1) JP2002534956A (fr)
AT (1) ATE393828T1 (fr)
AU (1) AU759724B2 (fr)
CA (1) CA2301374A1 (fr)
DE (1) DE69839426T2 (fr)
DK (1) DK1003888T3 (fr)
ES (1) ES2306478T3 (fr)
FR (1) FR2767337B1 (fr)
NZ (3) NZ519053A (fr)
PT (1) PT1003888E (fr)
WO (1) WO1999009186A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066143A1 (fr) * 1999-05-04 2000-11-09 The Public Health Research Institute Of The City Of New York, Inc. Proteines secretees par mycobacterium tuberculosis et utilisations comme vaccins et reactifs de diagnostic
DE19920712A1 (de) * 1999-05-05 2000-11-09 Rhein Biotech Proz & Prod Gmbh Verfahren zum Herstellen eines rekombinanten Proteines
AU7383500A (en) * 1999-09-17 2001-04-17 United States Government, As Represented By The Department Of Veteran's Affairs Virulence genes of m. marinum and m. tuberculosis
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
ES2282142T3 (es) * 1999-10-07 2007-10-16 Corixa Corporation Una secuencia de micobacterium tuberculosis para la expresion de proteinas heterologas.
NZ519667A (en) * 2002-06-19 2005-02-25 Univ Massey A putative 23kDa lipoprotein from Mycobacterium paratuberculosis and its use in Johne's disease
US7026467B2 (en) * 2002-07-19 2006-04-11 Arizona Board Of Regents, Acting For And On Behalf Of, Northern Arizona University High resolution typing system for pathogenic Mycobaterium tuberculosum
US7608277B2 (en) * 2004-12-01 2009-10-27 Gene Therapy Systems, Inc. Tuberculosis nucleic acids, polypeptides and immunogenic compositions
DE102005035586A1 (de) * 2005-06-29 2007-07-12 Grammer Ag Fahrzeugsitz mit einer flexiblen Rückenlehne
WO2007108829A2 (fr) * 2005-10-26 2007-09-27 Gene Therapy Systems, Inc. Acides nucléiques, polypeptides et compositions immunogènes de la tuberculose
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2822302A1 (fr) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Procedes pour alterer la differenciation osteoclaste
US7776341B2 (en) * 2006-08-10 2010-08-17 Colorado State University Research Foundation Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens
CA2668100C (fr) * 2006-11-01 2014-12-23 Immport Therapeutics, Inc. Composition et procedes pour des antigenes immunodominants
DE102009045951B4 (de) 2009-10-23 2020-07-16 Swg Schraubenwerk Gaisbach Gmbh Bohrschraube
FR2966827B1 (fr) 2010-10-27 2014-08-22 Kimonella Ventures Ltd Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
WO2012177520A2 (fr) * 2011-06-20 2012-12-27 Matthias Rath Oligopeptides et leur utilisation pour le traitement de maladies infectieuses
US9493562B2 (en) 2012-07-19 2016-11-15 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
US9611297B1 (en) 2016-08-26 2017-04-04 Thrasos Therapeutics Inc. Compositions and methods for the treatment of cast nephropathy and related conditions
CN113549604A (zh) * 2020-04-23 2021-10-26 中国医学科学院病原生物学研究所 结核分枝杆菌毒素抗毒素系统Rv1045-Rv1044及其在制备抗结核药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001796A1 (fr) * 1990-07-19 1992-02-06 Smithkline Beecham Biologicals (S.A.) Vecteurs
WO1996007745A2 (fr) * 1994-09-02 1996-03-14 Institut Pasteur Vecteurs de criblage et/ou d'expression fonctionnels chez les mycobacteries

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422956A1 (fr) 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
FR2464269B1 (fr) 1979-08-30 1986-04-18 Anvar Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr) 1981-12-23 1986-04-11 Pasteur Institut Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
GB8324800D0 (en) 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4582802A (en) * 1983-09-30 1986-04-15 The United States Of America As Represented By The Department Of Health And Human Services Stimulation of enzymatic ligation of DNA by high concentrations of nonspecific polymers
KR930000189B1 (ko) 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
AU601397B2 (en) 1986-01-22 1990-09-13 Institut Pasteur Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US4923901A (en) 1987-09-04 1990-05-08 Millipore Corporation Membranes with bound oligonucleotides and peptides
ES2116269T3 (es) 1989-03-21 1998-07-16 Vical Inc Expresion de secuencias exogenas de polinucleotidos en un vertebrado.
DK0490951T3 (da) 1989-09-06 1996-08-26 Pasteur Institut Nucleinsyrefragmenter fra en genom fra en egnet mycobakterie, deres anvendelse til diagnose af mycobakterieinfektioner samt plasmider indeholdende disse fragmenter
FR2663033B1 (fr) 1990-06-08 1992-09-04 Pasteur Institut Detection specifique du mycobacterium tuberculosis.
FR2696189B1 (fr) 1992-09-25 1994-11-10 Rhone Poulenc Rorer Sa Polypeptides impliqués dans la biosynthèse des streptogramines, séquences nucléotidiques codant pour ces polypeptides et leur utilisation.
WO1994027238A1 (fr) 1993-05-14 1994-11-24 Mds Health Group Ltd. Fichier electronique pour tests de microbiologie et etablissement de leurs rapports
CA2170148A1 (fr) * 1993-09-02 1995-03-09 Lee W. Riley Molecule d'adn codant l'absorption cellulaire de mycobacterium tuberculosis
FR2711670B1 (fr) 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5714593A (en) 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
FR2767336B1 (fr) * 1997-08-14 2001-05-18 Pasteur Institut Vecteurs recombinants, polynucleotide codant pour un polypeptide pd428 de 12kd de mycobacteries appartenant au complexe de mycobacterium tuberculosis et applications au diagnostic et a la prevention de la tuberculose

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001796A1 (fr) * 1990-07-19 1992-02-06 Smithkline Beecham Biologicals (S.A.) Vecteurs
WO1996007745A2 (fr) * 1994-09-02 1996-03-14 Institut Pasteur Vecteurs de criblage et/ou d'expression fonctionnels chez les mycobacteries

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ENG MONG LIM ET AL.: "Identification of Mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions", JOURNAL OF BACTERIOLOGY, vol. 177, no. 1, 1 January 1995 (1995-01-01), pages 59 - 65, XP000560419 *
SUJOY K. DAS GUPTA ET AL.: "Cloning and assessment of Mycobacterial promoters by using a plasmid shuttle vector", JOURNAL OF BACTERIOLOGY, vol. 175, no. 16, August 1993 (1993-08-01), pages 5186 - 5192, XP002063437 *
TIMM J. ET AL.: "Escherichia coli - Mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series", JOURNAL OF BACTERIOLOGY, vol. 176, no. 21, November 1994 (1994-11-01), pages 6749 - 6753, XP002063184 *
TIMM J. ET AL.: "Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer", MOLECULAR MICROBIOLOGY, vol. 12, no. 3, 1994, pages 491 - 504, XP002063436 *

Also Published As

Publication number Publication date
FR2767337A1 (fr) 1999-02-19
NZ529503A (en) 2005-12-23
ATE393828T1 (de) 2008-05-15
EP1950221A3 (fr) 2009-07-15
US20050158714A9 (en) 2005-07-21
PT1003888E (pt) 2008-07-01
US20040214165A1 (en) 2004-10-28
DE69839426T2 (de) 2009-05-20
EP1950221A2 (fr) 2008-07-30
WO1999009186A2 (fr) 1999-02-25
ES2306478T3 (es) 2008-11-01
FR2767337B1 (fr) 2002-07-05
US20070015173A1 (en) 2007-01-18
AU9076598A (en) 1999-03-08
EP1003888B1 (fr) 2008-04-30
NZ503316A (en) 2003-01-31
EP1003888A2 (fr) 2000-05-31
JP2002534956A (ja) 2002-10-22
NZ519053A (en) 2004-02-27
AU759724B2 (en) 2003-04-17
DK1003888T3 (da) 2008-07-28
US7244613B2 (en) 2007-07-17
CA2301374A1 (fr) 1999-02-25
DE69839426D1 (de) 2008-06-12

Similar Documents

Publication Publication Date Title
WO1999009186A3 (fr) Sequences nucleiques de polypeptides exportes de mycobacteries, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
CA2131826A1 (fr) Gene mn et proteine
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
GB2240979B (en) Fungal stress proteins
EP0784059A4 (fr) Polypeptide antigenique de chlamydia pneumoniae
WO1998053076A3 (fr) Composes permettant de diagnostiquer la tuberculose et leurs procedes d'utilisation
WO1998050554A3 (fr) POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS)
WO1997009429A3 (fr) Composes et methodes de diagnostic de la tuberculose
ATE420180T1 (de) Verbindungen zur immuntherapie und diagnose von tuberkulose und methoden zu deren verwendung
WO2000026248A3 (fr) Test de diagnostic de la tuberculose
SE9500023D0 (sv) Method of detecting cancer
EP1104887A3 (fr) Procédé pour la détermination des fragments de collagène dans les fluides corporels
WO1998016645A3 (fr) Composes et procedes pour diagnostiquer la tuberculose
MX9606463A (es) Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
WO1999047639A3 (fr) GENES ET POLYPEPTIDES DU $i(STAPHYLOCCOCUS AUREUS)
WO2000009709A3 (fr) Proteases et proteines associees
AU3618095A (en) Alk-7 (activin like kinase), a serine threonine kinase receptor
WO2000035950A3 (fr) Reactifs et methodes utiles pour la detection des pathologies du sein
IL128212A0 (en) Detection of small molecules by use of a piezo electric sensor
AU7564491A (en) New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
WO2000021986A3 (fr) Genes de remodelage de matrice
CA2241786A1 (fr) Nouvelles proteines kinases activees par l'amp
WO1990007000A3 (fr) Nucleotides codant la b1,4-galactosyltransferase humaine et leurs utilisations
WO2000008155A3 (fr) Proteines associees a un recepteur humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2301374

Country of ref document: CA

Ref country code: CA

Ref document number: 2301374

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/001612

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1998942748

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 503316

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 90765/98

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998942748

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 90765/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998942748

Country of ref document: EP